As negotiations continue, each side is blaming the other for problems in public hospitals. How did we get here?
Articles on Health funding
Displaying 1 - 20 of 48 articles
A modest increase in health funding is all that’s needed to save lives. That’s a big impact for the price of a fancy coffee.
New Zealand spends less on public health as a proportion of GDP than similar countries. Without a significant boost, the health system will remain stressed.
Foreign aid has helped, but it leaves African countries vulnerable to the political mood swings of funders.
The US withdrawal from the WHO will have a severe impact on HIV, polio and many other health programmes on the African continent.
Using ethnicity as a proxy for need is supported by local and international research. The government’s decision to get rid of it will mean worse outcomes for Māori and Pacific New Zealanders.
A government review into private hospitals has yet to be made public. In the meantime, here’s whether there’s a case for a government bail-out.
There is not enough money for New Zealand’s aged care sector – and the demand is only going to rise. The government needs to look at Australia for ways to ensure access for all.
New Zealand is not unique – health systems in most high-income countries are under stress. But that’s no reason to question the viability of the publicly-funded system in general.
Medicare encourages providers to deliver more services, not to deliver good quality care. Here’s why that needs to change.
Funding announced in this week’s federal budget moves Australia closer to eliminating HIV.
Here’s how we design a fairer pathology system, fit for the 21st century, with no out-of-pocket costs or the public.
It would be a wasted opportunity if our political leaders came back again in six months without a long-term plan about how to fund and improve the system.
While demand for subsidised services is high and rising, many parts of the system need improvement. The federal budget can’t solve these problems by placing the entire burden on taxpayers.
Our experts weigh up the winners and losers in a budget that had to balance an immediate cost-of-living crisis with long-term ambitions for health and climate change.
But are the major parties really focusing on the right issues?
Australia needs a new home-care model – one that provides much more personalised support to help older people get the services they need and that manages local service systems for them.
The new Community Pharmacy Agreement will make it easier for Australia’s pharmacists to spend time providing expert health advice to customers rather than focusing on retail revenues.
Canada is investing millions to develop COVID-19 treatments, but there are no safeguards to ensure that those vaccines and medications will be affordable and accessible to the people who need them.
How do we develop new drugs quickly yet safely? How prepared are we to give up some personal freedoms? And how do we allocate scarce resources? These are just some of the tough questions we face.
Top contributors
-
Honorary Enterprise Professor, School of Population and Global Health, and Department of General Practice and Primary Care, The University of Melbourne
-
Professorial Fellow, University of Canberra
-
Tim Tenbensel is a Friend of The Conversation.
Professor of Health Policy, University of Auckland, Waipapa Taumata Rau
-
Research Fellow/Research Uptake Officer of the Health Policy Research Group, University of Nigeria
-
Research Fellow, Health Economics, University of Tasmania
-
Extraordinary Professor, Global Health, Stellenbosch University; South African Medical Research Council
-
Head, Discipline of General Practice, University of Tasmania
-
Lecturer in Economics and Director, Business Taught Masters Programme, University of Canterbury
-
Associate Professor of Finance, UNSW Sydney
-
Professor of Orthopaedic Surgery, UNSW Sydney
-
Associate Professor, School of Population Health, University of Auckland, Waipapa Taumata Rau
-
Professor of Health Economics, Centre for Health Economics, Monash University
-
Jim Gillespie is a Friend of The Conversation.
Associate Professor in Health Policy, Leeder Centre for Health Policy, Economics and Data & Sydney School of Public Health, University of Sydney
-
Associate Professor, Brain and Mind Centre, University of Sydney; University of Canberra
-
Scientia Professor & Head of the School of Psychiatry, UNSW Sydney